Wells Fargo Upgrades PolyOne (POL) to Outperform; Raising Estimates After Positive Meeting with COO
Tweet
Share
E-mailGet Alerts POL Hot Sheet
Price: $1.82 --0%
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Wells Fargo upgraded PolyOne (NYSE: POL) from Market Perform to Outperform with a price target range $16-17.
Analyst, Frank J. Mitsch, said, "We are raising our rating on POL shares supported by a more attractive valuation on the recent retreat in share price, as well as on our increased earnings estimates. Over the past seven weeks, POL shares have dropped 11% (vs. a 6% increase in the S&P 500). We are also raising our 2012 EPS estimate from $1.12 to $1.20 [maintaining our Street High Q1 EPS of $0.28E (consensus $0.25)], and 2013 from $1.25 to $1.35, reflecting our increased confidence in the ColorMatrix (CM) contribution and improvement in housing."
For an analyst ratings summary and ratings history on PolyOne click here. For more ratings news on PolyOne click here.
Shares of PolyOne closed at $13.61 yesterday.
Analyst, Frank J. Mitsch, said, "We are raising our rating on POL shares supported by a more attractive valuation on the recent retreat in share price, as well as on our increased earnings estimates. Over the past seven weeks, POL shares have dropped 11% (vs. a 6% increase in the S&P 500). We are also raising our 2012 EPS estimate from $1.12 to $1.20 [maintaining our Street High Q1 EPS of $0.28E (consensus $0.25)], and 2013 from $1.25 to $1.35, reflecting our increased confidence in the ColorMatrix (CM) contribution and improvement in housing."
For an analyst ratings summary and ratings history on PolyOne click here. For more ratings news on PolyOne click here.
Shares of PolyOne closed at $13.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Upgrades Neurocrine Bio. (NBIX) to Overweight 'as the Company is Knocking on the Doors of the Large-Cap Club'
- Impinj (PI) Tops Q1 EPS by 11c, provides guidance
- Origin Bancorp, Inc. (OBK) Tops Q1 EPS by 13c
Create E-mail Alert Related Categories
Analyst EPS Change, UpgradesRelated Entities
Standard & Poor's, Earnings, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
